ripekg:evaluation/RIPEAA805A88D874EA69C |
rdf:type |
rdfs:Resource |
ripekg:evaluation/RIPEAA805A88D874EA69C |
rdf:type |
owl:Thing |
ripekg:evaluation/RIPEAA805A88D874EA69C |
rdf:type |
tido:Evaluation |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:endedAtTime |
2025-11-17T10:49:10.308636Z |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:startedAtTime |
2025-11-12T18:51:21.172671Z |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:used |
ripekg:publication-details/RIPEAA805A88D874EA69CThe optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:used |
ripekg:registry-evidence/RIPEAA805A88D874EA69C |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:used |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:wasAssociatedWith |
ripekg:human-reviewer/RV009 |
ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEAA805A88D874EA69C |
ripekg:evaluation/RIPEAA805A88D874EA69C |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-2-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-overall |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-inspectai-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-inspectai-1-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-inspectai-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-inspectai-2-2 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |